Medinfar, an exclusively Portuguese-owned pharmaceutical company, was set-up in 1970.
In recent years, the company has implemented a focused investment strategy policy. The successful outcome of this strategy is evident in increased production, product diversification, the nurturing of development projects - our own and those in collaboration with other enterprises - and in a firm commitment to Quality.
In 1996, our turnover was PTE 4 billion, thrusting us into 25th place in the ranking for our sector in Portugal.
Aside from our core business of providing the General Medicine, Cardiological, Gastroenterological and Dermatological areas with products, a major slice of our business is focused on OTC drugs and in equipment to hospitals and clinics.
When, in 1995, Medinfar acquired Laboratório Sorológico - the oldest Portuguese company producing animal-care drugs - we also began to branch out into the veterinary market not only with vaccines but with other drugs and equipment.
|Expertise gathered over time from working with leading international pharmaceutical corporations, allied to an ISO 9002-certified QA system, puts Medinfar in a privileged position as an attractive partner for any enterprise interested in introducing new drugs to Portugal.|
We are also proud to have been the promoters of an initiative created to stimulate and reward the careers of young researchers within the EU.
|The Medinfar European Prize in Physiology (as it is called) also serves to highlight the importance of Medinfar and of Portugal's pharmaceutical industry on the international arena.|
|Address||Rua Henrique de Paiva Couceiro, 27/29|
|Postal Code||2700-451 Amadora|
|Contact||Mr. João Almeida Lopes|
|Do you want to contact
Please fill out form